Gyanendra Kumar, M.D.

Open

• Strategy for Improving Stroke Treatment Response (SISTER) Trial (SISTER) Scottsdale/Phoenix, Ariz.

  The purpose of this study is to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.